✦ LIBER ✦

Anaphylaxis following the Intravenous Administration of Continuous Erythropoietin Receptor Activator in a Haemodialysis patient

✍ Scribed by Oh, Dong-Jin

Book ID: 124162115
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 79 KB
Volume: 19
Category: Article
ISSN: 1320-5358
DOI: 10.1111/nep.12213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monthly Administration of a Continuous E

Monthly Administration of a Continuous Erythropoietin Receptor Activator Provides Efficient Haemoglobin Control in Non-Dialysis Patients during Routine Clinical Practice

✍ Prof. Dr med. Stefan Heidenreich, Frank Leistikow, Stefan Zinn, Jörg Baumann, An 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 172 KB

Increased peripheral blood leukocyte cyt

Increased peripheral blood leukocyte cytotoxic activity in cancer patients during the continuous intravenous administration of recombinant human tumor necrosis factor

✍ Paul S. Charnetsky; Richard A. Greisman; Sydney E. Salmon; Evan M. Hersh; Philip 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 544 KB

Continuous Erythropoietin Receptor Activ

Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study

✍ A. L. M. DE FRANCISCO; W. SULOWICZ; M. KLINGER; S. NIEMCZYK; V. VARGEMEZIS; F. M 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

Efficacy and tolerability of intravenous

Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase ii, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease

✍ Anatole Besarab; Moro O. Salifu; N. Martin Lunde; Vinod Bansal; Steven Fishbane; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 1017 KB

Changes in sodium excretion in patients

Changes in sodium excretion in patients with cirrhosis of the liver following intravenous administration of albumin, mercurial diuretics and a low sodium diet

✍ William W. Faloon; Richard D. Eckhardt; Arnold N. Cooper; Charles S. Davidson 📂 Article 📅 1948 🏛 Elsevier Science 🌐 English ⚖ 235 KB

193: Safety and Tolerability of C.E.R.A.

193: Safety and Tolerability of C.E.R.A. (A Continuous Erythropoietin Receptor Activator) in Patients With Chronic Kidney Disease: Pooled Data From Ten Phase II-III Trials

✍ Rebecca Schmidt; Paula Dutka; Richard Beswick; Cheryl Dalton; Steven Fishbane 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 169 KB